Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Antonio Antela López"'
Autor:
Antonio Antela López
Publikováno v:
Enfermedades Infecciosas y Microbiología Clínica. 26:49-54
ART (antiretroviral therapy) currently continues to indefinitely prolong the survival of patients who live with HIV. Due to this, we are increasingly faced with specific problems that previously did not have time to develop or did not have the import
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3eb047e9ae684684849c1a25e4e91f38
https://doi.org/10.1016/s0213-005x(08)76621-7
https://doi.org/10.1016/s0213-005x(08)76621-7
Autor:
Antonio Antela López
Publikováno v:
Enfermedades Infecciosas y Microbiología Clínica. 26:32-36
Darunavir (DRV), previamente conocido como TMC-114, es un nuevo inhibidor de la proteasa (IP) con una alta afinidad por la proteasa del VIH-1, y una gran capacidad para inhibir su accion a pesar de que esta experimente mutaciones, por lo que se consi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00184278df37a190fc01041c61e28a8f
https://doi.org/10.1016/s0213-005x(08)76551-0
https://doi.org/10.1016/s0213-005x(08)76551-0
Autor:
Antonio Antela López
Publikováno v:
Medicine - Programa de Formación Médica Continuada Acreditado. 8:3923-3932
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b52d9c82f75a1462705876dc22ba7fcf
https://doi.org/10.1016/s0304-5412(02)70727-0
https://doi.org/10.1016/s0304-5412(02)70727-0
Autor:
Daniel, Podzamczer Palter, José A, Muñoz-Moreno, Daniel, Alcolea Rodríguez, Carlos, Alonso Villaverde, Antonio, Antela López, Jordi, Blanch Andreu, José Luis, Casado Osorio, M José, Galindo Puerto, Maite, Garolera i Freixa, Jaime, Locutura Rupérez, Albert, Lleó Bisa, Anna, Prats París, Ignacio, Pérez-Valero, Joaquín, Portilla Sogorb, Alex, Rovira Cañellas, M Jesús, Téllez Molina, Juan Manuel, Tiraboschi, Esperanza, Vergara Moragues, José Ramón, Arribas López, Miguel Ángel, Goenaga Sánchez, Fernando Lozano, de León-Naranjo, Esteban, Martínez Chamorro, Rosa, Polo Rodríguez, Daniel, Podzamczer
Publikováno v:
Enfermedades infecciosas y microbiologia clinica. 32(1)
To develop a consensus document containing clinical recommendations for the management of human immunodeficiency virus (HIV)-associated neurocognitive disorder (HAND).We assembled a panel of experts appointed by GeSIDA and the Secretariat of the Nati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0bb9a7648fa1d71f6b2b684c0d820eb5
https://pubmed.ncbi.nlm.nih.gov/23642283
https://pubmed.ncbi.nlm.nih.gov/23642283
Autor:
Antonio, Antela López
Publikováno v:
Enfermedades infecciosas y microbiologia clinica. 26
ART (antiretroviral therapy) currently continues to indefinitely prolong the survival of patients who live with HIV. Due to this, we are increasingly faced with specific problems that previously did not have time to develop or did not have the import
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c9722286e188ceffb288fa736ed7db42
https://pubmed.ncbi.nlm.nih.gov/20116618
https://pubmed.ncbi.nlm.nih.gov/20116618
Autor:
Antonio, Antela López
Publikováno v:
Enfermedades infecciosas y microbiologia clinica. 26
Darunavir, previously known as TMC-114, is a new protease inhibitor (PI) with a high affinity for the HIV-1 protease and strong ability to inhibit its action, even in mutated forms. Consequently, this drug is considered to have great intrinsic potenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::59f20b67969633f493eb827fa8d6798b
https://pubmed.ncbi.nlm.nih.gov/19195457
https://pubmed.ncbi.nlm.nih.gov/19195457